Activation of the Complement/Lectin Pathway, Angiopoietin/Tie‐2/VEGF‐System, Cytokines and Chemokines in Different Angioedema Subtypes
European Journal of Immunology · 2025
DOI: 10.1002/eji.70010 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Katharina Marlies Duda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, Comprehensive Allergy Center, Hereditary Angioedema Center for Rare Diseases, Hannover Medical School, Hannove…. Hauptthemen laut MEDLINE: Receptor, TIE-2, Vascular Endothelial Growth Factor A, Cytokines, Angioedema. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The precise molecular mechanisms underlying angioedema attacks in cases of C1‐inhibitor‐deficient hereditary angioedema (C1‐INH‐HAE), angiotensin‐converting enzyme inhibitor‐induced angioedema (ACEi‐AE), and mast cell‐/histamine‐mediated angioedema (Hist‐AE) are not well understood. These attacks may involve immune and inflammatory mechanisms. We compared serum biomarkers indicating vascular integrity, leakage, angiogenesis, coagulation, and inflammation. During an attack‐free period, we assessed 34 markers simultaneously using multi‐ and/or singleplex ELISA in 25 patients with C1‐INH‐HAE, 17 with ACEi‐AE, 25 with Hist‐AE, and 23 healthy controls. Differential blood counts, C1‐INH‐HAE‐specific laboratory parameters, and recently developed assays addressing early complement and lectin pathways were included. The results revealed significant differences, as well as some similarities. Tie‐2, VEGFs, C1s/C1INHc appear to play a role in all AE types regardless of whether they are bradykinin‐ or histamine‐mediated. Furthermore, evidence was found for a role of IL‐17, eosinophil, and neutrophil chemotactic factors, and the activation of these granulocytes was found. MASP‐1/C1‐INHc indicated early activation of the lectin pathway in ACEi‐AE and HistAE, but not in C1‐INH‐HAE. C1s/C1‐INHc and MASP‐1/C1INHc ratio was able to discriminate C1‐INH‐HAE from controls and the other AE types. Future investigations in C1‐INH‐HAE, ACEi‐AE, and Hist‐AE should not only focus on complement activation but also the interaction with granulocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Allergy, Comprehensive Allergy Center, Hereditary Angioedema Center for Rare Diseases, Hannover Medical School, Hannover, Germany.
ORCID-Profile: Bettina Wedi
Zitieren
APA
Duda, K. M., Gehring, M., & Wedi, B. (2025). Activation of the Complement/Lectin Pathway, Angiopoietin/Tie‐2/VEGF‐System, Cytokines and Chemokines in Different Angioedema Subtypes. European Journal of Immunology. https://doi.org/10.1002/eji.70010
Vancouver
Duda KM, Gehring M, Wedi B. Activation of the Complement/Lectin Pathway, Angiopoietin/Tie‐2/VEGF‐System, Cytokines and Chemokines in Different Angioedema Subtypes. European Journal of Immunology. 2025. doi:10.1002/eji.70010
BibTeX
@article{Duda2025,
author = {Duda, Katharina Marlies and Gehring, Manuela and Wedi, Bettina},
title = {Activation of the Complement/Lectin Pathway, Angiopoietin/Tie‐2/VEGF‐System, Cytokines and Chemokines in Different Angioedema Subtypes},
journal = {European Journal of Immunology},
year = {2025},
doi = {10.1002/eji.70010}
}
EUVIMED